Phase 2 Assessment of the Safety and Immunogenicity of Two Inactivated Pandemic Monovalent H1N1 Vaccines in Adults as a Component of the U.S. Pandemic Preparedness Plan in 2009

BACKGROUND: The influenza A/H1N1 pandemic in 2009 created an urgent need to develop vaccines for mass immunization. To guide decisions regarding the optimal immunization dosage and schedule for adults, we evaluated two monovalent, inactivated, unadjuvanted H1N1 influenza vaccines in independent, but...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Chen, Wilbur H., Winokur, Patricia L., Edwards, Kathryn M., Jackson, Lisa A., Wald, Anna, Walter, Emmanuel B., Noah, Diana L., Wolff, Mark, Kotloff, Karen L.
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3490194/
https://ncbi.nlm.nih.gov/pubmed/22537984
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2012.04.044
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados